Investment firm offers to buy 51% of Israeli med tech company at $18 per share
The offer represents a 29% premium over InMode's closing share price last Friday, before speculation around a potential transaction was reported in the media, Steel said.
Discuss the story with the TraceFeed community.
No comments yet. Be the first to add a perspective.